Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eculizumab in Guillain-Barré Syndrome (JET-GBS)
NCT02493725Phase 2Completed
- Sponsor
- Chiba University
- Start
- Jul 2015
- Primary completion
- May 2016
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of eculizumab in Guillain-Barré syndrome (GBS), sponsored by Chiba University. Started Jul 2015; status: completed.
02
Drugs
eculizumab
03
Conditions
Guillain-Barré syndrome (GBS)
Beyond the preview
Go deeper on NCT02493725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02493725.